Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: A case report

Journal of Cardiology

Volumn 36, Issue 3, 2000, Pages 183-189

  Ochiai, N ^a   Furukawa, K ^a   Ebizawa, T ^a   Yagi, T ^a   Akashi, K ^a   Nakamura, T ^a   Azuma, A ^a   Sugihara, H ^a  

^a Saiseikai Kyoto Hospital   (Japan)

Author keywords

Beta adrenergic receptor blockers (carvedilol); Cardiomyopathies, hypertrophic (familial dilated); Heart failure; Pacemaker, artificial; Radionuclide imaging (201Tl, 123I BMIPP)

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; THALLIUM 201;

AGED; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CARDIOMYOPATHY, CONGESTIVE; CASE REPORT; ENGLISH ABSTRACT; FATTY ACIDS; FEMALE; HEART FAILURE, CONGESTIVE; HUMAN; IODINE RADIOISOTOPES; IODOBENZENES; MIDDLE AGE; PROPANOLAMINES; THALLIUM RADIOISOTOPES;

EID: 0033778311     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
2. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy
3. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
4. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
6. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
7. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
8. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy
9. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia
10. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
11. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries
12. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (1)
13. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy
14. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
15. Mutations in the gene for gardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
16. 201Tl myocardial imaging
17. Progression of hypertrophic cardiomyopathy to dilated cardiomyopathy: A case report and review of the literatures
18. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage
19. Familial hypertrophic cardiomyopathy mimicing typical dilated cardiomyopathy
20. Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol
21. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction and oxidative stress in heart failure
22. Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy
23. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy
24. Fatty acid metabolic perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid
25. 123I-BMIPP)
26. Subcellular distribution of thallium: Morphological and quantitative study in rat myocardium